Amplia Therapeutics Limited (ASX:ATX)
Australia
· Delayed Price · Currency is AUD 0.0570
-0.0030 (-5.00%)
Jun 13, 2025, 3:58 PM AEST
Amplia Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is April - March.
Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 10.86 | 3.39 | 9.26 | 14.61 | 1.85 | Upgrade
|
| Cash & Short-Term Investments | 10.86 | 3.39 | 9.26 | 14.61 | 1.85 | Upgrade
|
| Cash Growth | 220.90% | -63.43% | -36.63% | 690.33% | 66.81% | Upgrade
|
| Other Receivables | 3.77 | 3.18 | 1.15 | 1.84 | 1 | Upgrade
|
| Receivables | 3.77 | 3.18 | 1.15 | 1.84 | 1 | Upgrade
|
| Prepaid Expenses | 0.11 | 0.07 | 0.04 | 0.03 | 0.05 | Upgrade
|
| Other Current Assets | 0.18 | 0.12 | 0.07 | 0.05 | 0.04 | Upgrade
|
| Total Current Assets | 14.93 | 6.75 | 10.51 | 16.53 | 2.94 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.1 | 0.18 | 0.01 | 0.01 | Upgrade
|
| Other Intangible Assets | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.05 | 0.05 | - | - | Upgrade
|
| Total Assets | 22.94 | 14.85 | 18.68 | 24.48 | 10.88 | Upgrade
|
| Accounts Payable | 1.56 | 1.6 | 0.35 | 0.37 | 0.49 | Upgrade
|
| Short-Term Debt | - | 1.49 | 2.11 | - | - | Upgrade
|
| Current Portion of Leases | 0.01 | 0.08 | 0.07 | - | - | Upgrade
|
| Other Current Liabilities | 0.31 | 0.23 | 0.22 | 0.16 | 0.05 | Upgrade
|
| Total Current Liabilities | 1.89 | 3.4 | 2.75 | 0.53 | 0.54 | Upgrade
|
| Long-Term Debt | - | - | - | 2.1 | - | Upgrade
|
| Long-Term Leases | - | 0.01 | 0.09 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.01 | 0 | 0.01 | - | Upgrade
|
| Total Liabilities | 1.91 | 3.43 | 2.85 | 2.64 | 0.54 | Upgrade
|
| Common Stock | 167.39 | 151.53 | 151.53 | 151.51 | 136.55 | Upgrade
|
| Retained Earnings | -145.54 | -139.01 | -134.72 | -128.62 | -125.21 | Upgrade
|
| Comprehensive Income & Other | -0.83 | -1.1 | -0.97 | -1.04 | -1.01 | Upgrade
|
| Shareholders' Equity | 21.02 | 11.42 | 15.84 | 21.85 | 10.34 | Upgrade
|
| Total Liabilities & Equity | 22.94 | 14.85 | 18.68 | 24.48 | 10.88 | Upgrade
|
| Total Debt | 0.01 | 1.59 | 2.28 | 2.1 | - | Upgrade
|
| Net Cash (Debt) | 10.85 | 1.8 | 6.98 | 12.51 | 1.85 | Upgrade
|
| Net Cash Growth | 503.17% | -74.23% | -44.19% | 576.70% | 66.81% | Upgrade
|
| Net Cash Per Share | 0.04 | 0.01 | 0.04 | 0.09 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 387.95 | 271.61 | 194.01 | 193.85 | 107.97 | Upgrade
|
| Total Common Shares Outstanding | 387.95 | 194.01 | 194.01 | 193.85 | 107.97 | Upgrade
|
| Working Capital | 13.04 | 3.35 | 7.76 | 16 | 2.4 | Upgrade
|
| Book Value Per Share | 0.05 | 0.06 | 0.08 | 0.11 | 0.10 | Upgrade
|
| Tangible Book Value | 13.09 | 3.48 | 7.9 | 13.91 | 2.4 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.02 | 0.04 | 0.07 | 0.02 | Upgrade
|
| Machinery | - | - | - | 0.02 | 0.01 | Upgrade
|
Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.